73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
New insight into BRCA2 gene mutations and cancer risk

New insight into BRCA2 gene mutations and cancer risk

A recent study from researchers at the University of California examines the BRCA2 gene, which plays a crucial role in repairing damaged DNA, and possible links with increased risk of breast and ovari

New insight into BRCA2 gene mutations and cancer risk

A recent study from researchers at the University of California examines the BRCA2 gene, which plays a crucial role in repairing damaged DNA, and possible links with increased risk of breast and ovari
What to Know About Blood Typing

What to Know About Blood Typing

What to Know About Blood TypingByNancy LeBrunPublished on July 14, 2023Medically reviewed bySteffini Stalos, DOYourblood typeis categorized by certain substances on

What to Know About Blood Typing

What to Know About Blood TypingByNancy LeBrunPublished on July 14, 2023Medically reviewed bySteffini Stalos, DOYourblood typeis categorized by certain substances on
Scientists find 'unknown link' between lung cancer and common parasite

Scientists find 'unknown link' between lung cancer and common parasite

by University of SalfordA picture of Toxoplasma infected cells in lung tissue.The brown-stained cells are those that contain the parasite. Credit: University of SalfordToxoplasma gondii, a micros

Scientists find 'unknown link' between lung cancer and common parasite

by University of SalfordA picture of Toxoplasma infected cells in lung tissue.The brown-stained cells are those that contain the parasite. Credit: University of SalfordToxoplasma gondii, a micros
Perioperative Durvalumab Plus Chemo Yields Responses, EFS Benefit in Resectable  NSCLC

Perioperative Durvalumab Plus Chemo Yields Responses, EFS Benefit in Resectable NSCLC

September 11, 2023Kyle DohertyThe addition of perioperative durvalumab to neoadjuvant chemotherapy led to a significant improvement in terms of pathological complete response and event-free survival c

Perioperative Durvalumab Plus Chemo Yields Responses, EFS Benefit in Resectable NSCLC

September 11, 2023Kyle DohertyThe addition of perioperative durvalumab to neoadjuvant chemotherapy led to a significant improvement in terms of pathological complete response and event-free survival c
Immunotherapy for Cancer: What Are My Options?

Immunotherapy for Cancer: What Are My Options?

ByJennifer WelshPublished on September 06, 2023Medically reviewed byDoru Paul, MDImmunotherapy is a relatively new approach to cancer treatment. It improves the body's immu

Immunotherapy for Cancer: What Are My Options?

ByJennifer WelshPublished on September 06, 2023Medically reviewed byDoru Paul, MDImmunotherapy is a relatively new approach to cancer treatment. It improves the body's immu
Large study shows no strong link between baby powder, ovarian cancer

Large study shows no strong link between baby powder, ovarian cancer

by Serena Gordon, Healthday Reporter(HealthDay)—There's been a longstanding debate—and a slew of lawsuits—over whether baby powder containing talc plays any role in the development of some cancers

Large study shows no strong link between baby powder, ovarian cancer

by Serena Gordon, Healthday Reporter(HealthDay)—There's been a longstanding debate—and a slew of lawsuits—over whether baby powder containing talc plays any role in the development of some cancers
Comparing cancer costs is challenging, despite new price transparency rules

Comparing cancer costs is challenging, despite new price transparency rules

byUNC Lineberger Comprehensive Cancer CenterUNC Lineberger's Trevor Royce, MD, MS, MPH, is author of a study that found a federal rule that requires hospitals to publicly list standard charg

Comparing cancer costs is challenging, despite new price transparency rules

byUNC Lineberger Comprehensive Cancer CenterUNC Lineberger's Trevor Royce, MD, MS, MPH, is author of a study that found a federal rule that requires hospitals to publicly list standard charg
AI beats human breast cancer diagnosis

AI beats human breast cancer diagnosis

by Patrick GaleyBreast scans are recommended for women above 50 who exhibit no signs of cancerA computer programme can identify breast cancer from routine scans with greater accuracy than human expert

AI beats human breast cancer diagnosis

by Patrick GaleyBreast scans are recommended for women above 50 who exhibit no signs of cancerA computer programme can identify breast cancer from routine scans with greater accuracy than human expert
Analysis of cancer treatment reveals need for standardized methods to measure waiting times

Analysis of cancer treatment reveals need for standardized methods to measure waiting times

byeLifeCredit: Pixabay/CC0 Public DomainA review of associations between cancer waiting times and treatment outcomes highlights inconsistencies in reporting that make it hard to draw firm conclu

Analysis of cancer treatment reveals need for standardized methods to measure waiting times

byeLifeCredit: Pixabay/CC0 Public DomainA review of associations between cancer waiting times and treatment outcomes highlights inconsistencies in reporting that make it hard to draw firm conclu
Liver cancer: Risk factors and prevention

Liver cancer: Risk factors and prevention

by Laurel Kelly,Mayo ClinicCredit: Pixabay/CC0 Public DomainOctober is Liver Cancer Awareness Month, which makes this a good time to learn more about risk factors for liver cancer and what you c

Liver cancer: Risk factors and prevention

by Laurel Kelly,Mayo ClinicCredit: Pixabay/CC0 Public DomainOctober is Liver Cancer Awareness Month, which makes this a good time to learn more about risk factors for liver cancer and what you c
Single set of criteria to assess progression in glioma aims to speed discovery of new medicines

Single set of criteria to assess progression in glioma aims to speed discovery of new medicines

byDana-Farber Cancer InstituteInfant high-grade glioma. Credit: David Ellison, St. Jude Children’s Research HospitalIn order to accurately assess the efficacy of novel therapies for brain tumors

Single set of criteria to assess progression in glioma aims to speed discovery of new medicines

byDana-Farber Cancer InstituteInfant high-grade glioma. Credit: David Ellison, St. Jude Children’s Research HospitalIn order to accurately assess the efficacy of novel therapies for brain tumors